Nurix Therapeutics, Inc. (NRIX)

Last Three Months

16-Feb-24 -- 15-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

7

0

2

+1

0

+2

0

+3

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-May-24 6:01 PM View:	02-May-24 Sale (Planned) ($44.88K)	van Houte Hans Chief Financial Officer		Nurix Therapeutics, Inc. - NRIX	(9%) 75.14K to 68.33K	0	0	--	--	Show Txns Hide Txns

30-Apr-24 6:33 PM View:	30-Apr-24 Option Sale ($24.17K)	Hansen Gwenn Chief Scientific Officer		Nurix Therapeutics, Inc. - NRIX	9% 36.4K to 39.6K	0	0	--	--	Show Txns Hide Txns

30-Apr-24 6:33 PM View:	30-Apr-24 Option Sale ($18.22K)	Ring Christine Chief Legal Officer		Nurix Therapeutics, Inc. - NRIX	14% 17.43K to 19.84K	0	0	--	--	Show Txns Hide Txns